These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16408927)

  • 1. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tagging-via-substrate strategy for probing O-GlcNAc modified proteins.
    Sprung R; Nandi A; Chen Y; Kim SC; Barma D; Falck JR; Zhao Y
    J Proteome Res; 2005; 4(3):950-7. PubMed ID: 15952742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of O-GlcNAc sites on proteins.
    Whelan SA; Hart GW
    Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
    Hédou J; Bastide B; Page A; Michalski JC; Morelle W
    Proteomics; 2009 Apr; 9(8):2139-48. PubMed ID: 19322778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.
    Slawson C; Housley MP; Hart GW
    J Cell Biochem; 2006 Jan; 97(1):71-83. PubMed ID: 16237703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.
    Greis KD; Hayes BK; Comer FI; Kirk M; Barnes S; Lowary TL; Hart GW
    Anal Biochem; 1996 Feb; 234(1):38-49. PubMed ID: 8742080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S; Vocadlo DJ
    Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
    Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc modification: a nutritional sensor that modulates proteasome function.
    Zachara NE; Hart GW
    Trends Cell Biol; 2004 May; 14(5):218-21. PubMed ID: 15130576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of Cu (I)-catalyzed alkyne-azide cycloaddition (CuAAC) and strain-promoted alkyne-azide cycloaddition (SPAAC) in O-GlcNAc proteomics.
    Li S; Zhu H; Wang J; Wang X; Li X; Ma C; Wen L; Yu B; Wang Y; Li J; Wang PG
    Electrophoresis; 2016 Jun; 37(11):1431-6. PubMed ID: 26853435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.
    Skorobogatko YV; Deuso J; Adolf-Bryfogle J; Nowak MG; Gong Y; Lippa CF; Vosseller K
    Amino Acids; 2011 Mar; 40(3):765-79. PubMed ID: 20563614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new O-GlcNAc modified proteins using a click-chemistry-based tagging.
    Gurcel C; Vercoutter-Edouart AS; Fonbonne C; Mortuaire M; Salvador A; Michalski JC; Lemoine J
    Anal Bioanal Chem; 2008 Apr; 390(8):2089-97. PubMed ID: 18369606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
    Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
    Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
    Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
    J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine.
    Comer FI; Vosseller K; Wells L; Accavitti MA; Hart GW
    Anal Biochem; 2001 Jun; 293(2):169-77. PubMed ID: 11399029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of O-GlcNAc modification of cellular proteins in signal transduction].
    Krześlak A
    Postepy Biochem; 2007; 53(4):389-99. PubMed ID: 19024903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAc modification of the extracellular domain of Notch receptors.
    Sakaidani Y; Furukawa K; Okajima T
    Methods Enzymol; 2010; 480():355-73. PubMed ID: 20816217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.